Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
People with pre-existing health conditions, pregnant or breastfeeding women, and those with certain types of cancer should consult with a healthcare professional before considering these treatments
Worth the EEfRT
Patient feedback matters for long-term safety
Three weeks in and already down 11 lbs
Retatrutide 2026: Everything Confirmed So Far Four Phase 3 trials now complete, confirming 20.828.7% weight loss across obesity, diabetes, and cardiovascular populations with the highest results in obesity-only trials and somewhat lower results where diabetes or cardiovascular disease was also present
US$ 28.20
US$ 22.45
US$ 20.41
US$ 23.73
US$ 25.79
US$ 26.72
US$ 27.24
US$ 23.02
